Litcius/Paper detail

Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic review

Julián M. Cota-Arce, J Menchaca Cota, Marco A. De León-Nava, Alexia Hernández-Cáceres, Leopoldo I. Moncayo-Salazar, Fidel Valle-Alvarado, Vera Larissa Cordero-Moreno, Karen L. Bonfil-Solis, Jesús E. Bichara-Figueroa, José A Hernández-Hernández, Luís Villela

2021Seminars in Arthritis and Rheumatism22 citationsDOI

Topics & Concepts

CanakinumabMedicineAnakinraRashObservational studyAdverse effectInternal medicineSystematic reviewArthritisRandomized controlled trialPlaceboCochrane LibraryClinical trialDiseaseDermatologyMEDLINEAlternative medicinePathologyPolitical scienceLawAutoimmune and Inflammatory Disorders ResearchInflammasome and immune disordersOtitis Media and Relapsing Polychondritis
Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic review | Litcius